Cerity Partners LLC raised its holdings in Koninklijke Philips (NYSE:PHG – Free Report) by 2.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 61,861 shares of the technology company’s stock after purchasing an additional 1,749 shares during the period. Cerity Partners LLC’s holdings in Koninklijke Philips were worth $1,684,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also made changes to their positions in PHG. Connor Clark & Lunn Investment Management Ltd. lifted its position in shares of Koninklijke Philips by 87.7% during the 4th quarter. Connor Clark & Lunn Investment Management Ltd. now owns 2,222,192 shares of the technology company’s stock valued at $56,266,000 after buying an additional 1,038,321 shares in the last quarter. Brandes Investment Partners LP raised its position in Koninklijke Philips by 4.9% during the fourth quarter. Brandes Investment Partners LP now owns 918,635 shares of the technology company’s stock worth $23,260,000 after acquiring an additional 43,157 shares during the period. Natixis Advisors LLC raised its position in Koninklijke Philips by 3.7% during the fourth quarter. Natixis Advisors LLC now owns 741,277 shares of the technology company’s stock worth $18,769,000 after acquiring an additional 26,227 shares during the period. Raymond James Financial Inc. purchased a new position in Koninklijke Philips during the fourth quarter valued at $10,655,000. Finally, Sei Investments Co. grew its position in shares of Koninklijke Philips by 5.2% in the fourth quarter. Sei Investments Co. now owns 308,673 shares of the technology company’s stock valued at $7,816,000 after purchasing an additional 15,395 shares during the period. 13.67% of the stock is currently owned by hedge funds and other institutional investors.
Koninklijke Philips Stock Down 0.4 %
Shares of NYSE PHG opened at $23.74 on Thursday. The stock has a market cap of $22.31 billion, a PE ratio of -28.26, a P/E/G ratio of 0.82 and a beta of 0.81. The company has a current ratio of 1.23, a quick ratio of 0.74 and a debt-to-equity ratio of 0.59. Koninklijke Philips has a 12-month low of $19.25 and a 12-month high of $32.91. The company has a 50-day moving average of $25.65 and a 200 day moving average of $26.83.
Koninklijke Philips Cuts Dividend
The business also recently declared an annual dividend, which will be paid on Friday, June 6th. Stockholders of record on Tuesday, May 13th will be issued a dividend of $0.886 per share. The ex-dividend date is Tuesday, May 13th. This represents a dividend yield of 2.9%. Koninklijke Philips’s dividend payout ratio is presently -89.29%.
Wall Street Analyst Weigh In
PHG has been the subject of several research analyst reports. StockNews.com raised shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a research note on Saturday, March 8th. Sanford C. Bernstein raised Koninklijke Philips from a “hold” rating to a “strong-buy” rating in a report on Tuesday, March 18th. UBS Group raised Koninklijke Philips from a “neutral” rating to a “buy” rating in a research note on Thursday, February 20th. Finally, BNP Paribas raised Koninklijke Philips from a “neutral” rating to an “outperform” rating in a research note on Tuesday, February 25th. Two analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.
Read Our Latest Analysis on Koninklijke Philips
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Read More
- Five stocks we like better than Koninklijke Philips
- Why is the Ex-Dividend Date Significant to Investors?
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- Stock Market Upgrades: What Are They?
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- Investing in Travel Stocks Benefits
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Want to see what other hedge funds are holding PHG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Koninklijke Philips (NYSE:PHG – Free Report).
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.